Rang	Name	Position
1	Mr. Thomas A. McCourt	CEO & Director
2	Ms. Tammi Gaskins	Senior Vice President & Chief Commercial Officer.
3	Mr. Ronald Silver	Senior VP, Interim CFO, Corporate Controller & Chief Accounting Officer
4	Dr. Rosario Lobrutto M.B.A., M.S., Ph.D.	VP & Global Head of Technical Operations
5	Mr. Chris Stamm	Vice President of Investor Relations & Communications
6	Mr. John Minardo	Senior VP, Chief Legal Officer & Secretary
7	Mr. Jeff Ruberti	Chief Strategy Officer
8	Dr. Jeffrey Silber M.D.	Chief Medical Officer, Head of Research & Drug Development

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Armistice Capital, LLC	9,09%	61,32 Mio. USD
2	BlackRock Inc	8,09%	54,52 Mio. USD
3	Sarissa Capital Management LP	5,56%	37,49 Mio. USD
4	Bank of America Corp	5,25%	35,43 Mio. USD
5	Renaissance Technologies Corp	4,88%	32,89 Mio. USD
6	AQR Capital Management LLC	4,56%	30,74 Mio. USD
7	State Street Corp	4,51%	30,42 Mio. USD
8	Vanguard Portfolio Management, LLC	4,04%	27,26 Mio. USD
9	Acadian Asset Management LLC	3,98%	26,84 Mio. USD
10	Vanguard Capital Management, LLC	3,69%	24,88 Mio. USD
11	Charles Schwab Investment Management Inc	2,87%	19,33 Mio. USD
12	Two Sigma Investments LLC	2,76%	18,59 Mio. USD
13	Geode Capital Management, LLC	2,75%	18,54 Mio. USD
14	Marshall Wace Asset Management Ltd	2,74%	18,46 Mio. USD
15	Jacobs Levy Equity Management, Inc.	2,20%	14,82 Mio. USD
16	Arrowstreet Capital Limited Partnership	2,06%	13,86 Mio. USD
17	Federated Hermes Inc	1,96%	13,18 Mio. USD
18	The Goldman Sachs Group Inc	1,63%	10,98 Mio. USD
19	Dimensional Fund Advisors, Inc.	1,53%	10,29 Mio. USD
20	Connor Clark & Lunn Inv Mgmt Ltd	1,11%	7,49 Mio. USD